p21可防止结直肠癌抗肿瘤免疫应答中CD4+ T细胞的耗竭
该研究利用小鼠结直肠癌模型和患者样本,探讨细胞周期调节因子p21在CD4+ T细胞抗肿瘤功能中的作用。发现p21活化对CD4+ T细胞毒性功能至关重要,p21缺陷的Th1细胞导致小鼠肿瘤生长增加,且患者肿瘤浸润CD4+ T细胞中p21低表达与癌症相关生存期缩短相关。体外使用CDK4/6抑制剂palbociclib处理p21缺陷T细胞可恢复其毒性功能并防止耗竭。
要点
- p21活化对CD4+ T细胞的细胞毒性功能至关重要。
- p21缺陷的Th1细胞在小鼠结直肠癌中导致肿瘤生长增加。
- 患者肿瘤浸润CD4+ T细胞中p21低表达与癌症相关生存期缩短相关。
核心结论
- p21在控制细胞周期和防止Th1细胞耗竭中具有重要作用。
- CDK抑制剂如palbociclib具有减少T细胞耗竭的治療潜力,可能用于未来结直肠癌患者的治疗。
研究设计与样本
- 研究使用小鼠结直肠癌模型研究p21在CD4+ T细胞中的功能作用。
- 评估了I至IV期结直肠癌患者中p21的表达。
- 使用体外共培养模型研究p21缺陷CD4+ T细胞的效应功能。
主要发现
- p21缺陷的Th1细胞显示出耗竭迹象,以效应/效应记忆T细胞积累和CD27/CD28丢失为主。
- 在携带肿瘤的Rag1-/-小鼠中,用palbociclib体外处理p21缺陷T细胞进行免疫重建,恢复了细胞毒性功能并防止了p21缺陷CD4+ T细胞的耗竭。
- 结直肠癌患者肿瘤浸润CD4+ T细胞中p21低表达与癌症相关生存期缩短相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: T cells are crucial for the antitumor response against colorectal cancer (CRC). T-cell reactivity to CRC is nevertheless limited by T-cell exhaustion. However, molecular mechanisms regulating T-cell exhaustion are only poorly understood. METHODS: We investigated the functional role of cyclin-dependent kinase 1a (Cdkn1a or p21) in cluster of differentiation (CD) 4+ T cells using murine CRC models. Furthermore, we evaluated the expression of p21 in patients with stage I to IV CRC. In vitro coculture models were used to understand the effector function of p21-deficient CD4+ T cells. RESULTS: We observed that the activation of cell cycle regulator p21 is crucial for CD4+ T-cell cytotoxic function and that p21 deficiency in type 1 helper T cells (Th1) leads to increased tumor growth in murine CRC. Similarly, low p21 expression in CD4+ T cells infiltrated into tumors of CRC patients is associated with reduced cancer-related survival. In mouse models of CRC, p21-deficient Th1 cells show signs of exhaustion, where an accumulation of effector/effector memory T cells and CD27/CD28 loss are predominant. Immune reconstitution of tumor-bearing Rag1-/- mice using ex vivo-treated p21-deficient T cells with palbociclib, an inhibitor of cyclin-dependent kinase 4/6, restored cytotoxic function and prevented exhaustion of p21-deficient CD4+ T cells as a possible concept for future immunotherapy of human disease. CONCLUSIONS: Our data reveal the importance of p21 in controlling the cell cycle and preventing exhaustion of Th1 cells. Furthermore, we unveil the therapeutic potential of cyclin-dependent kinase inhibitors such as palbociclib to reduce T-cell exhaustion for future treatment of patients with colorectal cancer.
引用
- Thoma OM, Naschberger E, Kubánková M, et al. p21 Prevents the Exhaustion of CD4+ T Cells Within the Antitumor Immune Response Against Colorectal Cancer. Gastroenterology. 2023. PMID: 37734420. doi:10.1053/j.gastro.2023.09.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。